Suchergebnisse - "Malet, Isabelle"

PubPharm (107)

1

HIV-1 resistance mutations to integrase inhibitors impair both integration and reverse transcription steps

enthalten in: International journal of antimicrobial agents | 2024

von Ratouit, P. | Malet, I. | Soulie, C. | +6

2

Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes

enthalten in: The Journal of infectious diseases | 2024

von Giammarino, F. | de Salazar, A. | Malet, I. | +23

3

Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients

enthalten in: Med (New York, N.Y.) | 2023

von Bruel, T. | Vrignaud, L. | Porrot, F. | +122

4

Three to four mRNA COVID-19 vaccines in multiple sclerosis patients on immunosuppressive drugs : Seroconversion and variant neutralization

enthalten in: European journal of neurology | 2023

von Louapre, C. | Belin, L. | Marot, S. | +11

5

SARS-CoV-2 variant-dependent inflammasome activation

enthalten in: The Journal of infection | 2023

von Teyssou, E. | Marot, S. | Gothland, A. | +8

6

Corrigendum : XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants

enthalten in: Frontiers in immunology | 2023

von Vanhove, B. | Marot, S. | So, R. | +14

ErratumFor: Front Immunol. 2021 Nov 15;12:761250. - PMID 34868003

7

Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy : a clue to the central nervous system involvement?

enthalten in: Free neuropathology | 2023

von Boluda, S. | Mokhtari, K. | Mégarbane, B. | +32

8

Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs : Seroconversion and variant neutralization

enthalten in: European Journal of Neurology | 2023

von Louapre, C. | Belin, L. | Marot, S. | +11

9

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence : Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test

enthalten in: Life (Basel, Switzerland) | 2022

von Marot, S. | Bocar Fofana, D. | Flandre, P. | +10

10

High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2

enthalten in: AIDS (London, England) | 2022

von Pourcher, V. | Belin, L. | Soulie, C. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]